Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Phreesia is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- S-3ASR2026-09-03S-3ASR
- 10-Q2026-09-03Quarterly report
- 8-K2026-09-02Current report (material event)
- SCHEDULE 13G2026-08-12SCHEDULE 13G
- 8-K2026-06-24Current report (material event)
- 10-Q2026-05-28Quarterly report
- 8-K2026-05-27Current report (material event)
- ARS2026-05-14Annual report to holders
- DEFA14A2026-05-14DEFA14A
- DEF 14A2026-05-14Proxy statement
- 8-K2026-05-11Current report (material event)
- 8-K2026-05-04Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-03Current report (material event)
- SCHEDULE 13D/A2026-04-02SCHEDULE 13D/A
- S-82026-03-31Employee stock plan
- 10-K2026-03-31Annual report
- 8-K2026-03-30Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- SCHEDULE 13D/A2026-03-19SCHEDULE 13D/A
- 8-K2026-03-16Current report (material event)
- 8-K2026-02-23Current report (material event)
- SCHEDULE 13D2026-02-19SCHEDULE 13D
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-05SCHEDULE 13G/A
- 8-K/A2026-01-28Current report (amended)
- SCHEDULE 13G/A2026-01-08SCHEDULE 13G/A
- 10-Q2025-12-09Quarterly report
- 8-K2025-12-08Current report (material event)
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
- 8-K2025-11-12Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- 10-Q2025-09-05Quarterly report
- 8-K2025-09-04Current report (material event)
- SCHEDULE 13G2025-08-13SCHEDULE 13G
- SCHEDULE 13G2025-08-12SCHEDULE 13G
- SCHEDULE 13G/A2025-08-06SCHEDULE 13G/A
- SCHEDULE 13G/A2025-07-08SCHEDULE 13G/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.